Understanding how TGF-β2 is activated for heart and blood vessel repair
Latent TGF-β2 Structure and Activation
This study is looking at a protein called TGF-β2 that plays a key role in heart and blood vessel health, to better understand how it works and how it might be involved in heart problems like aortic aneurysms and cardiac fibrosis, which could help find new ways to treat these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11049066 on NIH RePORTER |
What this research studies
This research investigates the structure and activation mechanisms of TGF-β2, a protein essential for heart and vascular development and repair. By examining how TGF-β2 is regulated and activated, the research aims to uncover the underlying processes that contribute to cardiovascular conditions like aortic aneurysms and cardiac fibrosis. The study employs advanced techniques such as X-ray crystallography and cryo-electron microscopy to visualize the interactions between TGF-β2 and other molecules in the body. This could lead to new insights into how to manipulate TGF-β2 for therapeutic purposes.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with cardiovascular conditions such as aortic aneurysms, cardiac fibrosis, or those with genetic mutations affecting TGF-β2.
Not a fit: Patients without cardiovascular issues or those not affected by TGF-β2 dysregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for cardiovascular diseases linked to TGF-β2 dysregulation.
How similar studies have performed: Other research has shown promising results in understanding TGF-β signaling pathways, indicating potential for success in this area.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Springer, Timothy a — Boston Children's Hospital
- Study coordinator: Springer, Timothy a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.